Dunstable GP surgery criticised over woman’s opioid death
A coroner says no plan was in place to reduce a women dosage of “dependency forming drugs”.
Similar Posts
The Best Walking Shoes For Older Adults, According To Podiatrists
For people who walk frequently, choosing the right walking shoe is super important to prevent your feet from aching and developing or worsening painful foot conditions. But wearing the proper supportive footwear is especially essential for older adults, said Dr. Chanel J. Perkins, a board-certified podiatrist based in Texas. “Supportive shoes help maintain balance and alignment,…
SEC charges ex-CEO of medical device company with fraud, says some devices were ‘just a piece of plastic’
The headquarters of the U.S. Securities and Exchange Commission (SEC) is seen in Washington, D.C., May 12, 2021. Andrew Kelly | Reuters Laura Tyler Perryman, co-founder and former CEO of the medical device startup Stimwave Technologies, was charged with allegedly defrauding investors out of $41 million by making “false and misleading” statements about one of…
Bayer’s new CEO plans to cut management jobs in prelude to overhaul | Reuters News Agency
Business & FinanceHealth 15 September 2023, 1:53 pm 1 minute Reuters exclusively reported that Bayer’s (BAYGn.DE) new CEO plans to cut management jobs to speed up decision-making as a first step to overhaul the embattled German industrial group, which is facing investor pressure to break up. Market Impact Anderson has been tasked with reviving Bayer’s…
10 Over-The-Counter Drugs You Can Get “Addicted” To
George Resch, who goes by TankSinatra on social media, recently mentioned that he had an addiction to the over-the-counter nasal spray Afrin. “I have been congested for a year,” he said on the podcast Meme Daddies. How does that happen? Plenty of over-the-counter medications — those that are sold on pharmacy and grocery store shelves…
Covid Inquiry: What have we learnt so far?
The first phase of the Covid Inquiry has come to an end. What have we learnt over the past six weeks?
Prescriptions for Eli Lilly’s new weight-loss drug get off to a strong start and confirm bright outlook
The launch of Eli Lilly ‘s weight-loss drug Zepbound — a key pillar of our investment thesis in the pharmaceuticals giant — is going swimmingly in the U.S., Jefferies said Friday. Weekly Zepbound prescriptions totaled 7,700 in the week ended Dec. 8, its fourth on the U.S. market, according to Jefferies, which cited data compiled…
